This is a working overview of Certificate of analysis, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-08-01 and is reviewed periodically as new material appears.
Stability of GW501516 depends on form, temperature, light exposure, and moisture. Solid reference material is typically stored frozen or refrigerated in a desiccator and protected from light. Solutions in organic solvents such as dimethyl sulfoxide are often kept frozen in aliquots to reduce freeze-thaw cycling. Aqueous solubility is low, so aqueous stock solutions can be difficult to prepare without cosolvents. Degradation may appear as changes in chromatographic purity or mass spectral signal. Stability studies are needed to establish shelf life for any specific preparation.
Quality assessment for cardarine samples usually combines identity, purity, and impurity testing. Nuclear magnetic resonance spectroscopy and mass spectrometry can confirm molecular structure, while high-performance liquid chromatography estimates purity. Certificates of analysis from testing laboratories may list these results, but they do not establish safety or legality. In the absence of approved manufacturing, products sold online may contain the wrong compound, variable amounts, or unlisted contaminants. Independent verification is therefore central to analytical work and to interpreting any reported biological activity.
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.
Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Common for reference-grade material. |
| Solubility | Low in water | Dissolves in DMSO and some organic solvents. |
| Typical storage | -20 °C, desiccated | Protect from light and moisture. |
| Analytical method | LC-MS/MS | Used for trace detection in biological matrices. |
| Purity assessment | HPLC with UV detection | Often combined with NMR and mass spectrometry. |
Because cardarine is not an approved medicine, no pharmacopeial monograph defines its identity, purity, or storage requirements. Laboratories typically rely on in-house methods and reference standards when testing materials labeled as GW501516. Certificates of analysis may report purity and identity for a specific batch, but their scope varies and they do not guarantee safety or legal status. Independent verification can include high-performance liquid chromatography, mass spectrometry, nuclear magnetic resonance, and elemental analysis. The distinction between research chemical labeling and human use is significant because quality standards and oversight differ.
Cardarine can be detected in biological samples and product materials using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). The method separates compounds by chromatography and identifies them by mass-to-charge transitions, allowing low-level detection in urine or blood. Sample preparation often involves enzymatic hydrolysis, solid-phase extraction, or protein precipitation. Certified reference materials and isotope-labeled internal standards improve quantification. Detection windows depend on metabolism, matrix, and assay sensitivity, so no single universal window applies.
Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.
Laboratory studies indicate that GW501516 activates PPARδ, a nuclear receptor involved in fatty acid oxidation and energy metabolism. In rodent experiments, treated animals often showed increased endurance and reduced fat mass. These effects were observed under controlled conditions and do not establish safe or effective use in humans. The exact dose-response relationship in humans remains poorly characterized. Species differences in metabolism can affect how results translate across animals and people.
Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.
==== LC16m8 ==== LC16m8 is a minimally replicating attenuated strain of vaccinia that is manufactured by Kaketsuken in Japan. In November 2024, WHO added LC16m8 to its Emergency Use Listing following updated safety data. It has been found to be safe and effective, including in people with well-controlled HIV. Because the strain remains able to "minimally" replicate, it should not be used in immunocompromised people such as people with immunodeficiency, people taking immunosuppressants, and people with a CD4 cell count of less than 200 cells/μL. It is commercially known as LC16 KMB. Working at the Chiba Serum Institute in Japan, So Hashizume passaged the Lister strain 45 times in primary rabbit kidney cells, interrupting the process after passages 36, 42, and 45 to grow clones on chorioallantoic membrane and select for pock size. The resulting variant was designated LC16m8 (Lister clone 16, medium pocks, clone 8). Unlike the severely-damaged MVA, LC16m8 contains every gene that is present in the ancestral vaccinia. However, a single-nucleotide deletion truncates membrane protein B5R from a residue length of 317 to 92. Although the truncated protein decreases production of extracellular enveloped virus, animal models have shown that antibodies against other membrane proteins are sufficient for immunity. LC16m8 was approved in Japan in 1975 after testing in over 50,000 children. Vaccination with LC16m8 results in a vaccine "take", but safety is similar to MVA.
"Chamber acid" and "tower acid" were the two concentrations of sulfuric acid produced by the lead chamber process, chamber acid being the acid produced in the lead chamber itself (<70% to avoid contamination with nitrosylsulfuric acid) and tower acid being the acid recovered from the bottom of the Glover tower. They are no longer used in commercial applications, although they may be prepared in the laboratory from concentrated sulfuric acid if needed. In particular, "10 M" sulfuric acid (the modern equivalent of chamber acid, used in many titrations) is prepared by slowly adding 98% sulfuric acid to an equal volume of water, with good stirring: the temperature of the mixture can rise to 80 °C (176 °F) or higher.
On 18 July 1966, the ICJ ruled that it had no authority to decide on the South West African affair. Furthermore, the court found that while Ethiopia and Liberia had locus standi to institute proceedings on the matter, neither had enough vested legal interest in South West Africa to entitle them to a judgement of merits. This ruling was met with great indignation by SWAPO and the OAU. SWAPO officials immediately issued a statement from Dar es Salaam declaring that they now had "no alternative but to rise in arms" and "cross rivers of blood" in their march towards freedom. Upon receiving the news, SWALA escalated its insurgency. Its third group, which had infiltrated Ovamboland in July, attacked white-owned farms, traditional Ovambo leaders perceived as South African agents, and a border post. The guerrillas set up camp at Omugulugwombashe, one of five potential bases identified by SWALA's initial reconnaissance team as appropriate sites to train future recruits. Here, they drilled up to thirty local volunteers between September 1965 and August 1966. South African intelligence became aware of the camp by mid 1966 and identified its general location. On 26 August 1966, the first major clash of the conflict took place when South African paratroops and paramilitary police units executed Operation Blouwildebees to capture or kill the insurgents. SWALA had dug trenches around Omugulugwombashe for defensive purposes, but was taken by surprise and most of the insurgents quickly overpowered. SWALA suffered 2 dead, 1 wounded, and 8 captured; the South Africans suffered no casualties.
mitochondrion (pl.) mitochondria; also formerly chondriosome. A highly pleiomorphic membrane-bound organelle found in the cytoplasm of nearly all eukaryotic cells, usually in large numbers in the form of sausage-shaped structures 5–10 micrometres in length, enclosed by a double membrane, with the inner membrane infolded in an elaborate series of cristae so as to maximize surface area. Mitochondria are the primary sites of ATP synthesis, where ATP is regenerated from ADP via oxidative phosphorylation, as well as many supporting pathways, including the citric acid cycle and the electron transport chain. Like other plastids, mitochondria contain their own genome encoded in circular DNA molecules which replicate independently of the nuclear genome, as well as their own unique set of transcription factors, polymerases, ribosomes, transfer RNAs, and aminoacyl-tRNA synthetases with which to direct transcription and translation of their genes. The majority of the structural proteins found in mitochondria are encoded by nuclear genes, however, such that mitochondria are only partially autonomous. These observations suggest mitochondria evolved from symbiotic prokaryotes living inside eukaryotic cells.
=== Structure === Polyphenols, such as lignin, are larger molecules (macromolecules). Their upper molecular weight limit is about 800 daltons, which allows for the possibility to rapidly diffuse across cell membranes so that they can reach intracellular sites of action or remain as pigments once the cell senesces. Hence, many larger polyphenols are biosynthesized in situ from smaller polyphenols to non-hydrolyzable tannins and remain undiscovered in the plant matrix. Most polyphenols contain repeating phenolic moieties of pyrocatechol, resorcinol, pyrogallol, and phloroglucinol connected by esters (hydrolyzable tannins) or more stable C-C bonds (nonhydrolyzable condensed tannins). Proanthocyanidins are mostly polymeric units of catechin and epicatechin.
Sources: en.wikipedia.org
=== Models === It was suggested that the problem with building and maintaining larger, more complex, and more accurately replicated molecules can be circumvented if several information carriers, each of them storing a small piece of information, are connected such that they only control their own concentration. Studies of the mathematical model describing replicating molecules revealed that to observe a cooperative behaviour among self-replicating molecules, they have to be connected by a positive feedback loop of catalytic actions. This kind of closed network consisting of self-replicating entities connected by a catalytic positive-feedback loop was named an elementary hypercycle. Such a concept, apart from an increased information capacity, has another advantage. Linking self-replication with mutual catalysis can produce nonlinear growth of the system. This, first, makes the system resistant to so-called parasitic branches. Parasitic branches are species coupled to a cycle that do not provide any advantage to the reproduction of a cycle, which, in turn, makes them useless and decreases the selective value of the system. Secondly, it reinforces the self-organization of molecules into the hypercycle, allowing the system to evolve without losing information, which solves the error threshold problem.
State institutions that were allowed to perform sterilizations on patients that seemed like the perfect candidate, was very common. Current research shows that Latinas were targets for sterilization at higher rates than white women. The disproportion among sterilization rates in the Latino community could not be quantified in its current time, but data from sterilization forms suggest that 88 percent of Californians with a Spanish last name were of Mexican origin and descent. The surnames of people in forms recommending institutionalized patients between 1920 and 1945 shows that Latino were more likely to be sterilized than non-Latino men and Latina women experienced sterilization at higher rates than non-Latina women. This data shows that there was an unfair application of the California law that allowed institutions to take health measures for other people on their behalf.
It often happens that the amount of antibody available to the researcher for their immunoprecipitation experiment is less than sufficient to saturate the agarose beads to be used in the immunoprecipitation. In these cases the researcher can end up with agarose particles that are only partially coated with antibodies, and the portion of the binding capacity of the agarose beads that is not coated with antibody is then free to bind anything that will stick, resulting in an elevated background signal due to non-specific binding of lysate components to the beads, which can make data interpretation difficult. While some may argue that for these reasons it is prudent to match the quantity of agarose (in terms of binding capacity) to the quantity of antibody that one wishes to be bound for the immunoprecipitation, a simple way to reduce the issue of non-specific binding to agarose beads and increase specificity is to preclear the lysate, which for any immunoprecipitation is highly recommended.
=== Ion exchange mechanism === Another extraction mechanism is known as the ion exchange mechanism. Here, when an ion is transferred from the aqueous phase to the organic phase, another ion is transferred in the other direction to maintain the charge balance. This additional ion is often a hydrogen ion; for ion exchange mechanisms, the distribution ratio is often a function of pH. An example of an ion exchange extraction would be the extraction of americium by a combination of terpyridine and a carboxylic acid in tert-butyl benzene. In this case
=== 1989 === 9 July Moving Pictures, with Sir Jonathan Miller, the documentary explains how the brain sees images, with relation to television; Gotthold Ephraim Lessing and his work Laocoön; animator Sergio Simonetti; the National Science and Media Museum in Bradford; the Asteroid theme of Pearl & Dean; cognitive scientist Jerome Lettvin; John Grover and the 1989 film Licence to Kill; with the documentary editor Simon Rose. Produced by Patrick Uden, directed by Michael Proudfoot, made by Uden Associates 23 July The Bicycle: The Green Machine, Columbus of Italy that made cycle steel tubing from 130 kg steel billets; Cinelli of Milan; sports scientist Adrienne Hardman of Loughborough University; cycle chains were mostly made in Japan; 2m would be sold in UK - 700k by Raleigh. Narrated by the Radio 4 newsreader John Hedges, produced by Jeremy Llewellyn-Jones, made by Chrysalis Television 30 July Earth Calling Basingstoke, about Guy Hurst, who collates sightings for The Astronomer (BAA); Dave Graham from Brompton-on-Swale; John Wall, known for his Crayford focuser; the documentary was filmed around April 1989, and the astronomers in County Durham saw the effects of the March 1989 geomagnetic storm.
Sources: en.wikipedia.org
LC-MS/MS is common, often after sample cleanup. The assay targets GW501516 or its metabolites.
Reference material is usually kept cold, dry, and protected from light. Frozen aliquots reduce repeated freeze-thaw cycles.
No approved pharmaceutical product exists, so manufacturing and quality controls are not standardized. Products may contain different compounds or impurities.
No. Cardarine is GW501516, a PPARδ agonist, while SARMs act on androgen receptors. The two classes are often grouped in informal discussions despite different mechanisms.